Also Included In: Allergy; Transplants / Organ Donations; Respiratory / Asthma
Article Date: 30 Jul 2012 - 1:00 PDT
Current ratings for:
Research Findings May Affect How Doctors Treat Allergic Inflammation And Organ Transplant Rejection
| Patient / Public: |  | |
| Healthcare Prof: | |
A research team led by Xian Chang Li, MD, PhD, Brigham and Women's Hospital (BWH) Transplantation Research Center, has shed light on how a population of lymphocytes, called CD4+ T cells, mature into various subsets of adult T helper cells. In particular, the team uncovered that a particular cell surface molecule, known as OX40, is a powerful inducer of new T helper cells that make copious amounts of interleukin-9 (IL-9) (and therefore called TH9 cells) in vitro; such TH9 cells are responsible for ongoing inflammation in the airways in the lungs in vivo.
The study was published online in Nature Immunology on July 29, 2012.
In their studies, the researchers found that mice with hyper-active OX40 activities had signs of tissue inflammation, particularly in tissues lining the airway. A high amount of cells - as much as 30 percent - in these tissues were mucin-producing cells. Mucin-producing cells produce gel-like secretions that, when combined with other secretions, can form mucus or saliva.
The results mirrored previous studies of mice who over expressed IL-9 in the lung airways. Results from additional experiments confirmed that OX40 triggers both TH9 cell and IL-9 production, thereby leading to airway inflammation.
"These findings may have broad impact on how to treat chronic inflammation, such as allergic inflammation and chronic allograft rejection after transplantation, since the inflammatory texture organized by TH9 cells tends to be different and ongoing." said Li.
In addition to this translational finding, Li and his team made strides in better understanding OX40's role in the molecular mechanisms of the pathway responsible for TH9 cell induction.
According to Li, the revelation that OX40 promotes TH9 cells through TRAF6 (a protein that mediates cell signaling) and the activation of a non-canonical NF-kB pathway will point to new opportunities in drug discovery and development in treatment of TH9-related diseases.
Visit our immune system / vaccines section for the latest news on this subject.
Brigham and Women's Hospital
MLA
n.p. "Research Findings May Affect How Doctors Treat Allergic Inflammation And Organ Transplant Rejection." Medical News Today. MediLexicon, Intl., 30 Jul. 2012. Web.
3 Aug. 2012. <http://www.medicalnewstoday.com/releases/248413.php>
APA
http://www.medicalnewstoday.com/releases/248413.php.
Please note: If no author information is provided, the source is cited instead.
'Research Findings May Affect How Doctors Treat Allergic Inflammation And Organ Transplant Rejection'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Source: http://www.medicalnewstoday.com/releases/248413.php
Read Full Article Read Full Report Get the facts Related Site
No comments:
Post a Comment